TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH 6-MERCAPTOPURINE
摘要
<p>Methods of administering a delayed release 6-mercaptopurine pharmaceutical composition to patients suffering from inflammatory bowel disease which provide for release of the 6-mercaptopurine after passage of the pharmaceutical composition through the stomach are disclosed. The methods result in significant clinical improvement despite leading to very little systemic absorption of 6-mercaptopurine and also result in very few undesirable side effects.</p>
申请公布号
WO2009128955(A1)
申请公布日期
2009.10.22
申请号
WO2009US02460
申请日期
2009.04.20
申请人
TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;ROSENBERGER, VERED;KOLATCH, BRENDA;MARSHALL, LINDA SUSAN;HOTOVELY-SALOMON, ANNA
发明人
ROSENBERGER, VERED;KOLATCH, BRENDA;MARSHALL, LINDA SUSAN;HOTOVELY-SALOMON, ANNA